{"title":"[Identification of water buffalo horn and its adulterants using COI barcode].","authors":"Xu-zhao Liu, Li-si Zhou, Jin-xin Liu, Jing Jia, Jing-yuan Song, Lin-chun Shi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Bubali cornu (water buffalo horn) has been used as the substitute for Cornu rhinoceri asiatici\n(rhino horn) in clinical applications, and is the essential ingredient of Angong Niuhuang Wan. In recent years,\nthere are a number of adulterants on the commercial herbal medicine markets. An efficient tool is required\nfor species identification. In this study, 155 Bubali cornu samples have been taken from original animals and\ncollected from commercial herbal medicine markets. 153 COI sequences have been successfully obtained\nfrom 155 samples through DNA extraction, PCR amplification, bidirectional sequencing and assembly. 93\nCOI sequences have been added to the DNA barcoding database of traditional Chinese animal medicine after\nvalidation using DNA barcoding GAP and tree-based methods. The species identification of the 62 commercial\nBubali cornu medicines has been accomplished on the DNA barcoding system for identifying herbal medicine\nusing the updated animal medicine database (www.tcmbarcode.cn). Except two samples failed to obtain COI\nsequences, 54.8% of the commercial Bubali cornu medicines were water buffalo horns and 29% were yak horns.\nOur results showed that yak horn was the major adulterant of Bubali cornu and the DNA barcoding method may\naccurately discriminate Bubali cornu and their adulterants. Therefore, we recommend that supervision on the\nherbal medicine markets should be strengthened with this new method to warren the effectiveness of herbal\nmedicines.</p>","PeriodicalId":35924,"journal":{"name":"药学学报","volume":"52 3","pages":"494-9"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"药学学报","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Bubali cornu (water buffalo horn) has been used as the substitute for Cornu rhinoceri asiatici
(rhino horn) in clinical applications, and is the essential ingredient of Angong Niuhuang Wan. In recent years,
there are a number of adulterants on the commercial herbal medicine markets. An efficient tool is required
for species identification. In this study, 155 Bubali cornu samples have been taken from original animals and
collected from commercial herbal medicine markets. 153 COI sequences have been successfully obtained
from 155 samples through DNA extraction, PCR amplification, bidirectional sequencing and assembly. 93
COI sequences have been added to the DNA barcoding database of traditional Chinese animal medicine after
validation using DNA barcoding GAP and tree-based methods. The species identification of the 62 commercial
Bubali cornu medicines has been accomplished on the DNA barcoding system for identifying herbal medicine
using the updated animal medicine database (www.tcmbarcode.cn). Except two samples failed to obtain COI
sequences, 54.8% of the commercial Bubali cornu medicines were water buffalo horns and 29% were yak horns.
Our results showed that yak horn was the major adulterant of Bubali cornu and the DNA barcoding method may
accurately discriminate Bubali cornu and their adulterants. Therefore, we recommend that supervision on the
herbal medicine markets should be strengthened with this new method to warren the effectiveness of herbal
medicines.
药学学报Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.20
自引率
0.00%
发文量
0
期刊介绍:
Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent advances. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953. The journal is co-published by Elsevier B.V., in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.